Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 7/20 | 0.68 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.68 |
| ▸ | CHRNA1 | P02708 | 4/20 | 0.68 |
| ▸ | CHRNG | P07510 | 4/20 | 0.68 |
| ▸ | CHRNB1 | P11230 | 4/20 | 0.68 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.68 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.68 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.68 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.68 |
| ▸ | CHRND | Q07001 | 4/20 | 0.68 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.68 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | HRH1 | P35367 | 1/20 | 0.68 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.68 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL340227 | 1.00 | SLC6A2 (0.68) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 | |
| SCHEMBL1686427 | 1.00 | SLC6A2 (0.68) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 | |
| Hydrochloric Acid SCHEMBL12497918 | 0.99 | SLC6A2 (0.68) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 | |
| SCHEMBL770048 | 0.89 | SLC6A2 (0.68) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 | |
| SCHEMBL769847 | 0.86 | SLC6A2 (0.64) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 | |
| SCHEMBL4874443 | 0.86 | SLC6A2 (0.64) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 | |
| SCHEMBL13151517 | 0.86 | SLC6A2 (0.68) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 | |
| SCHEMBL634045 | 0.84 | SLC6A2 (0.61) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 | |
| SCHEMBL769133 | 0.84 | SLC6A2 (0.61) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 | |
| SCHEMBL633272 | 0.83 | SLC6A2 (0.60) | SLC6A2SLC6A3CHRNA1CHRNGCHRNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2821 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| EP-4593814-A1 | COMBINATION FOR USE IN A METHOD OF PREVENTING WEIGHT GAIN | Rose Research Center, LLC (US) | 2025-08-06 | — | — | EP | claimed |
| US-20250073186-A1 | COMBINATION TREATMENT METHODS | ROSE RESEARCH CENTER, LLC | 2025-03-06 | — | — | US | claimed |
| CN-119555831-A | Liquid chromatography mass spectrometry detection method for simultaneously measuring seven key probe substrate metabolites in CYP (CYP inhibition) inhibition test | 上海药明康德新药开发有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-113396332-B | Method for evaluating pregnancy progression and premature abortion for clinical intervention and use thereof | 斯坦福大学托管董事会 | 2025-02-11 | — | — | CN | claimed |
| WO-2024077133-A1 | TRANSDERMAL DELIVERY OF DEXTROMETHORPHAN | SHINKEI THERAPEUTICS, INC. (US) | 2024-04-11 | — | — | WO | claimed |
| WO-2024073334-A1 | COMBINATION FOR USE IN A METHOD OF PREVENTING WEIGHT GAIN | ROSE RESEARCH CENTER, LLC (US) | 2024-04-04 | — | — | WO | claimed |
| EP-4337181-A1 | COMBINATION TREATMENT METHODS | Rose Research Center, LLC (US) | 2024-03-20 | — | — | EP | claimed |
| CN-117693335-A | Combination therapy method | 罗斯研究中心有限责任公司 | 2024-03-12 | — | — | CN | claimed |
| CN-117007693-A | 23 antidepressants and 17 metabolites detection method | 河南中医药大学第一附属医院 | 2023-11-07 | — | — | CN | claimed |
| WO-2006092691-A1 | USE OF PDE7 INHIBITORS FOR THE TREATMENT OF NEUROPATHIC PAIN | PFIZER LIMITED (GB) | 2006-09-08 | — | — | WO | claimed |
| EP-1691811-A1 | COMBINATION OF A SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR IMPROVING SLEEP QUALITY AND TREATING DEPRESSION | Sepracor, Inc. (US) | 2006-08-23 | — | — | EP | claimed |
| EP-1602369-A2 | Bupropion Metabolites and Methods of their Synthesis and Use | Sepracor, Inc. (US) | 2005-12-07 | — | — | EP | claimed |
| WO-2005098429-A2 | SYSTEM AND METHOD FOR REAL-TIME DIAGNOSIS, TREATMENT, AND THERAPEUTIC DRUG MONITORING | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2005-10-20 | — | — | WO | claimed |
| US-20050233459-A1 | Marker detection method and apparatus to monitor drug compliance | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2005-10-20 | — | — | US | claimed |
| WO-2005060968-A1 | COMBINATION OF A SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR IMPROVING SLEEP QUALITY AND TREATING DEPRESSION | SEPRACOR INC. (US) | 2005-07-07 | — | — | WO | claimed |
| US-20050054942-A1 | System and method for therapeutic drug monitoring | UNIVERSITY OF FLORIDA | 2005-03-10 | — | — | US | claimed |
| EP-1259243-A2 | BUPROPION METABOLITES AND METHODS OF THEIR SYNTHESIS AND USE | SEPRACOR, INC. (US) | 2002-11-27 | — | — | EP | claimed |
| US-20020052341-A1 | Bupropion metabolites and methods of their synthesis and use | SEPRACOR INC. | 2002-05-02 | — | — | US | claimed |
| WO-2001062257-A2 | BUPROPION METABOLITES AND METHODS OF THEIR SYNTHESIS AND USE | SEPRACOR INC. (US) | 2001-08-30 | — | — | WO | claimed |